{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:25:06Z","timestamp":1792855506790,"version":"4.5.0"},"reference-count":30,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T00:00:00Z","timestamp":1721606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>This study aimed to measure the associations between different inflammatory factors, namely interleukin (IL)-17A, tumor necrosis factor (TNF)-\u03b1, and high-sensitivity C-reactive protein (hs-CRP), and atherosclerosis in patients with psoriasis vulgaris.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A cross-sectional study was conducted at two hospitals in Hanoi, Vietnam. A total of 125 patients with psoriasis vulgaris and 50 healthy controls were recruited. Clinical characteristics and atherosclerosis were assessed. IL-17A, TNF-\u03b1, and hs-CRP levels were measured.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Psoriasis vulgaris patients with atherosclerosis had higher levels of hs-CRP (median\u2009=\u20091.22; interquartile range\u2014IQR\u2009=\u20090.34\u201312.11) and IL-17A (median\u2009=\u20091.30; IQR\u2009=\u20090.43\u20134.28), but a lower level of TNF-\u03b1 (median\u2009=\u20090.54; IQR\u2009=\u20090.13\u20133.41) compared to those without atherosclerosis (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05). Only LogIL-17A was positively related to atherosclerosis in psoriasis patients (Odds Ratio\u2014OR\u2009=\u20092.16, 95% CI\u2009=\u20091.06\u20134.38, <jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05). After excluding systemically treated patients, LogIL-17A and Log TNF-\u03b1 were associated with the likelihood of atherosclerosis (<jats:italic>p<\/jats:italic>\u2009&amp;lt;\u20090.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>This study suggests a link between elevated levels of IL-17A and TNF-\u03b1 and subclinical atherosclerosis. Further investigation on a larger scale is required to establish the causality of this relationship.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2024.1396680","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T04:58:30Z","timestamp":1721624310000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Associations of different inflammatory factors with atherosclerosis among patients with psoriasis vulgaris"],"prefix":"10.3389","volume":"11","author":[{"given":"Nguyen Thi Kim","family":"Huong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bui","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le Huu","family":"Doanh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tran Minh","family":"Thoai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen Thi","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Khoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pham Thi","family":"Nu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2024,7,22]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(07)61128-3","article-title":"Pathogenesis and clinical features of psoriasis","volume":"370","author":"Griffiths","year":"2007","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1016\/j.jaad.2006.08.040","article-title":"Prevalence of cardiovascular risk factors in patients with psoriasis","volume":"55","author":"Neimann","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1161\/CIRCULATIONAHA.116.026859","article-title":"Coronary plaque characterization in psoriasis reveals high-risk features that improve after treatment in a prospective observational study","volume":"136","author":"Lerman","year":"2017","journal-title":"Circulation"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.3389\/fimmu.2018.01234","article-title":"Potential immunological links between psoriasis and cardiovascular disease","volume":"9","author":"Sajja","year":"2018","journal-title":"Front Immunol"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"adv5087","DOI":"10.2340\/actadv.v103.5087","article-title":"Cardiovascular screening practices and statin prescription habits in patients with psoriasis among dermatologists, rheumatologists and primary care physicians","volume":"103","author":"Berna-Rico","year":"2023","journal-title":"Acta Derm Venereol"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1038\/s41569-021-00668-4","article-title":"Therapeutic strategies targeting inflammation and immunity in atherosclerosis: how to proceed?","volume":"19","author":"Engelen","year":"2022","journal-title":"Nat Rev Cardiol"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jaad.2018.02.040","article-title":"Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis","volume":"79","author":"Lockshin","year":"2018","journal-title":"J Am Acad Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","article-title":"Psoriasis","volume":"397","author":"Griffiths","year":"2021","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"e0211808","DOI":"10.1371\/journal.pone.0211808","article-title":"Subclinical atherosclerosis in psoriasis. Usefulness of femoral artery ultrasound for the diagnosis, and analysis of its relationship with insulin resistance","volume":"14","author":"Gonzalez-Cantero","year":"2019","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1016\/j.amjcard.2011.11.025","article-title":"Coronary artery disease in patients with psoriasis referred for coronary angiography","volume":"109","author":"Armstrong","year":"2012","journal-title":"Am J Cardiol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1161\/CIRCULATIONAHA.114.014310","article-title":"Prevalence, vascular distribution, and multiterritorial extent of subclinical atherosclerosis in a middle-aged cohort: the PESA (progression of early subclinical atherosclerosis) study","volume":"131","author":"Fern\u00e1ndez-Friera","year":"2015","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/s41577-021-00584-1","article-title":"How the immune system shapes atherosclerosis: roles of innate and adaptive immunity","volume":"22","author":"Roy","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/ced.14180","article-title":"Effect of biologics targeting interleukin-23\/\u221217 axis on subclinical atherosclerosis: results of a pilot study","volume":"45","author":"Marovt","year":"2020","journal-title":"Clin Exp Dermatol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1016\/j.jid.2018.10.042","article-title":"Impact of Secukinumab on endothelial dysfunction and other cardiovascular disease parameters in psoriasis patients over 52 weeks","volume":"139","author":"von Stebut","year":"2019","journal-title":"J Invest Dermatol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"e13628","DOI":"10.1111\/dth.13628","article-title":"High-sensitivity C-reactive protein as a biomarker in detecting subclinical atherosclerosis in psoriasis","volume":"33","author":"Niknezhad","year":"2020","journal-title":"Dermatol Ther"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"13831","DOI":"10.1038\/s41598-017-14365-1","article-title":"IFN-\u03b3 and TNF-\u03b1 synergism may provide a link between psoriasis and inflammatory atherogenesis","volume":"7","author":"Mehta","year":"2017","journal-title":"Sci Rep"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1159\/000250839","article-title":"Severe psoriasis--oral therapy with a new retinoid","volume":"157","author":"Fredriksson","year":"1978","journal-title":"Dermatologica"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.amjcard.2016.05.060","article-title":"Lipoprotein metabolism and inflammation in patients with psoriasis","volume":"118","author":"Armstrong","year":"2016","journal-title":"Am J Cardiol"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.clim.2008.01.009","article-title":"The Th17\/Treg imbalance in patients with acute coronary syndrome","volume":"127","author":"Cheng","year":"2008","journal-title":"Clin Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1111\/jdv.16273","article-title":"The role of the interleukin-23\/Th17 pathway in cardiometabolic comorbidity associated with psoriasis","volume":"34","author":"Egeberg","year":"2020","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1093\/eurheartj\/ehr425","article-title":"Psoriasis and atherosclerosis: two plaques, one syndrome?","volume":"33","author":"Flammer","year":"2012","journal-title":"Eur Heart J"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.cyto.2013.03.013","article-title":"IL-17 in psoriasis: implications for therapy and cardiovascular co-morbidities","volume":"62","author":"Golden","year":"2013","journal-title":"Cytokine"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s00415-009-5017-6","article-title":"High-sensitivity C-reactive protein at different stages of atherosclerosis: results of the INVADE study","volume":"256","author":"Schulze Horn","year":"2009","journal-title":"J Neurol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4103\/2229-5178.160256","article-title":"Serum levels of hypersensitive-C-reactive protein in moderate and severe acne","volume":"6","author":"Namazi","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"460","DOI":"10.7439\/ijbar.v4i7.407","article-title":"A study of serum hsCRP level to assess severity in patients with psoriasis (a study of 50 patients and 50 controls)","volume":"4","author":"Agravatt","year":"2013","journal-title":"Int J Biomed Adv Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/2042018816637312","article-title":"Serum chemerin and high-sensitivity C reactive protein as markers of subclinical atherosclerosis in Egyptian patients with type 2 diabetes","volume":"7","author":"Lachine","year":"2016","journal-title":"Ther Adv Endocrinol Metab"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/clc.23095","article-title":"Relationship between high-sensitivity C-reactive protein and subclinical carotid atherosclerosis stratified by glucose metabolic status in Chinese adults","volume":"42","author":"Su","year":"2019","journal-title":"Clin Cardiol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"322","DOI":"10.4103\/2229-5178.164483","article-title":"Role of C-reactive protein as a marker of disease severity and cardiovascular risk in patients with psoriasis","volume":"6","author":"Vadakayil","year":"2015","journal-title":"Indian Dermatol Online J"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/j.jacc.2021.02.009","article-title":"Cardiovascular risk in patients with psoriasis: JACC review topic of the week","volume":"77","author":"Garshick","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"3096","DOI":"10.3389\/fimmu.2019.03096","article-title":"IL-17A in psoriasis and beyond: cardiovascular and metabolic implications","volume":"10","author":"von Stebut","year":"2020","journal-title":"Front Immunol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1396680\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T04:58:33Z","timestamp":1721624313000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2024.1396680\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,22]]},"references-count":30,"alternative-id":["10.3389\/fmed.2024.1396680"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2024.1396680","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,22]]},"article-number":"1396680"}}